ESMO 2023: Checkpoint Post-Conference Report

Our Beacon Checkpoint experts have screened each abstract from the 2023 ESMO Congress, held on 20th-24th October. This year, an astounding 333 checkpoint-relevant abstracts (329 clinical and 4 preclinical) were identified and have been listed in order of presentation in our Post-Conference Report.

ESMO 2023: Checkpoint Abstract Highlights

This report provides a complete guide to all the checkpoint-relevant abstracts presented at the 2023 ESMO Congress, offering you a concise summary of each abstract as well as additional analysis.

You May Also Be Interested In…

Learn More About Checkpoint

What is Beacon Checkpoint?
  • The Most Comprehensive Way to Search the Checkpoint Drug Development Landscape: Unique search ontologies based on Checkpoint drug and trial characteristics
  • Market Leading Approach to Checkpoint Preclinical & Clinical Data Curation: Manual curation of key Checkpoint research and development data points by Checkpoint research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Checkpoint company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Checkpoint

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search